[
  {
    "ts": null,
    "headline": "Seeking Clues to Aon (AON) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics",
    "summary": "Get a deeper insight into the potential performance of Aon (AON) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.",
    "url": "https://finnhub.io/api/news?id=486c0a2626c23e066c33fc604ae846d7982d78ea014bcdcf7df12a9ccf5fae10",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753190103,
      "headline": "Seeking Clues to Aon (AON) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics",
      "id": 136033641,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AON",
      "source": "Yahoo",
      "summary": "Get a deeper insight into the potential performance of Aon (AON) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.",
      "url": "https://finnhub.io/api/news?id=486c0a2626c23e066c33fc604ae846d7982d78ea014bcdcf7df12a9ccf5fae10"
    }
  },
  {
    "ts": null,
    "headline": "More Than 40 American Oncology Network Clinics Across 18 States and Washington, D.C., Now Offering Bispecific T-cell Engager Therapies to Patients",
    "summary": "AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard-to-treat cancersFORT MYERS, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, is now offering Bispecific T-cell Engager (BiTE) therapy—also known as BiTE therapy—at more than 40 partner practice clinics in 18 states and Washington, D.C. This advancement brings cutting-edge",
    "url": "https://finnhub.io/api/news?id=6a1c954985aa2b27d060abc4bd68b573af951d300d8ec1b214247ab8670980c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753185600,
      "headline": "More Than 40 American Oncology Network Clinics Across 18 States and Washington, D.C., Now Offering Bispecific T-cell Engager Therapies to Patients",
      "id": 136031795,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AON",
      "source": "Yahoo",
      "summary": "AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard-to-treat cancersFORT MYERS, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, is now offering Bispecific T-cell Engager (BiTE) therapy—also known as BiTE therapy—at more than 40 partner practice clinics in 18 states and Washington, D.C. This advancement brings cutting-edge",
      "url": "https://finnhub.io/api/news?id=6a1c954985aa2b27d060abc4bd68b573af951d300d8ec1b214247ab8670980c3"
    }
  }
]